We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Apotex Gets Second Warning for Continuing GMP Issues
Apotex Gets Second Warning for Continuing GMP Issues
April 16, 2010
Apotex’s Toronto facility has received an FDA warning letter citing several good manufacturing practice (GMP) deficiencies for finished products,
including the alleged use of contaminated ingredients.